Search

Letters / BY: Doug McFee, MD May 2008
Clinical Articles / BY: Helen Novak Lauscher, PhD May 2008
... and men (44%) will develop cancer over their lifetimes.[ 2 ]  Cancer control includes a spectrum of health-related ... practitioners report providing to patients.   Table 2  summarizes practitioners’ responses to questions about ...
Clinical Articles / BY: Borys Flak, MD, FRCPC, May 2008
... yearly provincial loss of over 7000 productive years.[ 2 ] Three-quarters of all CRC occurs in asymptomatic ... and women between age 50 and 74 determined that only 13.2% of these average-risk patients had been advised by a ... are acquired at 0.5 mm resolution and reconstructed at 2 mm collimation at 25 to 30 mAs and 120 kVp. Such thin ...
Clinical Articles / BY: Barbara Poole Lane, MPA May 2008
... while accounting for changes in background risks.[ 2 ]  The results of this modeling estimated that the ... 12 to 18 months and women age 50 to 79 be screened every 2 years. The current BCCA guidelines for diagnosis of breast ... for screening high-risk populations, as shown in  Table 2 .[ 15-18 ] The inheritance of a BRCA1 or BRCA2 mutation ...
Obituaries / BY: Ruth Elwood Martin, MD, FCFP, MPH June 2008
... William Carlos Williams’s poetry or The Problem of Pain[ 2 ] while the rest of us swotted our anatomy textbooks.  ...
Letters / BY: James M. Wright, MD, PhD, FRCPC June 2008
... Letter 68 entitled “Gly­cemic targets in type 2 diabetes.” We agree with their conclusion that “the ... of the two most recent trials looking at glycemic targets. 2. The data we quote and the reference we use are on the NIH ...
Letters / BY: Ehud Ur, MBBS, FRCPC June 2008
... search and their criteria for inclusion/exclusion. 2. Much of the evidence they quote is taken from a press ...
Letters / BY: H. Davis, MD, June 2008
... references in the literature with, among others, Jennett.[ 2 ]  An editorial in the British Journal of Psychiatry[ 3 ] ...
Letters / BY: Pearce Wilcox, MD, June 2008
... survival benefit yet demonstrated (17% relative risk or 2.6% absolute risk reduction for salmeterol/fluticasone,[ 2 ] not quite reaching the P<.05 level of significance) and ... or mortality. The larg­est study evaluating (a) ICS/LABA[ 2 ] reported reductions in exacerbation frequency and ...
Council on Health Promotion / BY: Roy Purssell, MD, FRCPC June 2008
... treated in hospital are convicted of impaired driving.[ 2 ] In the second study, characteristics and conviction rates ...